distribut product servic
veterinari water test dairi market
leader pet healthcar innov
rang diagnost
revenu
requir disclosur end report
great quarter littl snap disappoint
reiter buy decreas pt
view current cl king meet event calendar coverag univers
post solid financi beat top bottom line
rais organ growth revenu guidanc bp fx modest
impact report guidanc larg expect reassess
fecal antigen littl disappoint sure product
sleev thesi three driver growth new
product refer lab market share gain robust growth outsid unit
state lead above-guid long-term revenu growth
signific oper margin expans reiter buy rate lower
price target still street-high
happen print solid top bottom line beat
organ revenu margin expans outlook expect
premium instrument placement well ahead expect howev
note fecal antigen delay notic
estim compani intern forecast fecal antigen contribut
like less although model
think enough bag trick make miss
product keep rate unchang
result report revenu report
basi organ basi versu year-ago period come
street estim respect
ep also beat our/th street estim
year year
guidanc revenu rais organ growth guidanc
bp recent strength
dollar bring report number midpoint
rais ep guidanc
investor spoke
awar fx would headwind
margin expans stori valid new guidanc actual reflect
expect bp organ oper margin expans
bp despit improv dollar would actual
consist consensu model long term expect oper margin
expans least bp next half decad fact central
recommend valuat level confid margin
placement report strong premium instrument placement
versu estim includ catalyst hematolog
instrument sedivu sedivu number blew estim
sinc placement either requir veterinarian make capit
expenditur minimum use contract expect drive futur
fecal antigen snap reassess fecal antigen snap
roughli million fecal worm test run annual still believ
convert fecal antigen test refer
lab promis fecal antigen point-of-car poc meant
veterinarian could drive much higher complianc grow market
meaning dont think refer lab drive complianc
lower rapid test estim
analyst day host analyst day august
admittedli littl disappoint news fecal antigen
delay perhap indefinit possibl
product sleev analyst day tradit analyst day
focus long-term valuat creation announc new
product think smaller side there also potenti
new product back half
model lower revenu forecast
rais ep estim reflect updat
guidanc also lower respect revenu ep estim
addit decreas
revenu ep estim
respect updat model essenti account fx
chang subtract fecal antigen expect
revis price target base price-to-earnings multipl
unchang new estim
risk achiev price target
risk includ currenc geopolit environ relianc distributor
regul multipl sole supplier vet industri macro situat price
concess competit
new york citi see list compani confirm regist click
page
